Dingdang Health Executes HKD 0.10 Million Share Buyback, Lifts Treasury Stock to 4.06 Million Shares

Bulletin Express09-10

Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed a repurchase of 120,000 ordinary shares on 10 September 2026, conducted on the Hong Kong Stock Exchange under its existing buyback mandate. The shares were acquired at prices ranging between HKD 0.79 and HKD 0.815, resulting in a volume-weighted average cost of HKD 0.8065 per share and a total cash outlay of HKD 96.78 thousand.

Following the transaction, Dingdang Health’s issued share capital (excluding treasury shares) declined by 0.0097% to 1.23625 billion shares, while treasury shares rose to 4.06 million. The total number of issued shares remained unchanged at 1.24031 billion, as the repurchased stock has been retained as treasury shares rather than cancelled.

The buyback forms part of the company’s general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.92 million shares, equivalent to 0.56% of the issued share base on the mandate date. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issues or further treasury share disposals until 10 October 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1192486419?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 18:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1192486419","market":"us","top_or_hot":-1,"title":"Dingdang Health Executes HKD 0.10 Million Share Buyback, Lifts Treasury Stock to 4.06 Million Shares","media":"Bulletin Express","content":"<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed a repurchase of 120,000 ordinary shares on 10 September 2026, conducted on the Hong Kong Stock Exchange under its existing buyback mandate. The shares were acquired at prices ranging between HKD 0.79 and HKD 0.815, resulting in a volume-weighted average cost of HKD 0.8065 per share and a total cash outlay of HKD 96.78 thousand.</p>\n<p>Following the transaction, Dingdang Health’s issued share capital (excluding treasury shares) declined by 0.0097% to 1.23625 billion shares, while treasury shares rose to 4.06 million. The total number of issued shares remained unchanged at 1.24031 billion, as the repurchased stock has been retained as treasury shares rather than cancelled.</p>\n<p>The buyback forms part of the company’s general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.92 million shares, equivalent to 0.56% of the issued share base on the mandate date. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issues or further treasury share disposals until 10 October 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Executes HKD 0.10 Million Share Buyback, Lifts Treasury Stock to 4.06 Million Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Executes HKD 0.10 Million Share Buyback, Lifts Treasury Stock to 4.06 Million Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-09-10 18:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed a repurchase of 120,000 ordinary shares on 10 September 2026, conducted on the Hong Kong Stock Exchange under its existing buyback mandate. The shares were acquired at prices ranging between HKD 0.79 and HKD 0.815, resulting in a volume-weighted average cost of HKD 0.8065 per share and a total cash outlay of HKD 96.78 thousand.</p>\n<p>Following the transaction, Dingdang Health’s issued share capital (excluding treasury shares) declined by 0.0097% to 1.23625 billion shares, while treasury shares rose to 4.06 million. The total number of issued shares remained unchanged at 1.24031 billion, as the repurchased stock has been retained as treasury shares rather than cancelled.</p>\n<p>The buyback forms part of the company’s general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.92 million shares, equivalent to 0.56% of the issued share base on the mandate date. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issues or further treasury share disposals until 10 October 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1192486419","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1192486419","pubTimestamp":1789035736,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed a repurchase of 120,000 ordinary shares on 10 September 2026, conducted on the Hong Kong Stock Exchange under its existing buyback...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康"},"translate_title":"叮当健康执行10万港元股票回购，库存股增至406万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health Technology Group Ltd. (Dingdang Health) disclosed a repurchase of 120,000 ordinary shares on 10 September 2026, conducted on the Hong Kong Stock Exchange under its existing buyback mandate. The shares were acquired at prices ranging between HKD 0.79 and HKD 0.815, resulting in a volume-weighted average cost of HKD 0.8065 per share and a total cash outlay of HKD 96.78 thousand.\nFollowing the transaction, Dingdang Health’s issued share capital (excluding treasury shares) declined by 0.0097% to 1.23625 billion shares, while treasury shares rose to 4.06 million. The total number of issued shares remained unchanged at 1.24031 billion, as the repurchased stock has been retained as treasury shares rather than cancelled.\nThe buyback forms part of the company’s general mandate approved on 23 June 2026, which authorises repurchases of up to 124.32 million shares. Cumulative repurchases under this mandate now stand at 6.92 million shares, equivalent to 0.56% of the issued share base on the mandate date. In accordance with Hong Kong listing rules, Dingdang Health is subject to a moratorium on new share issues or further treasury share disposals until 10 October 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1192486419","isCrawlerRequest":true}